Sign In
Buy MRK
$115.49
+0.320 (+0.278%)
At Close: Jun 17, 2026
Merck & Co., Inc. (MRK) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript
12:56pm, Tuesday, 10'th Jun 2025
Merck & Co., Inc. (NYSE:MRK ) Goldman Sachs 46th Annual Global Healthcare Conference June 10, 2025 10:00 AM ET Company Participants Dean Y. Li - Executive VP & President of Merck Research Laboratories
5 Ideal 'Safe' Buys From June Fortune Return On Leadership Screen
12:47pm, Tuesday, 10'th Jun 2025
Coincident to the June 5, 2025 annual launch of their Fortune 500, Fortune also partnered with Indiggo to measure Return On Leadership, called the ROL100. Arnold research focused on those 100 using Y
Merck Secures FDA Nod for New RSV Antibody Enflonsia in Infants
11:51am, Tuesday, 10'th Jun 2025
MRK wins early FDA approval for RSV antibody Enflonsia in infants, with U.S. launch planned before the 2025-26 season.
RFK Jr.'s firing of CDC vaccine advisors 'circumvents science' and could threaten public health, experts say
11:50am, Tuesday, 10'th Jun 2025
Health and Human Services Secretary Robert F. Kennedy Jr. has gutted a key government panel of vaccine advisors, a stunning move that some public health experts say undermines science, disrupts a trus
Will Merck's Keytruda Continue to Drive Growth Amid Looming LOE?
10:50am, Tuesday, 10'th Jun 2025
MRK leans on Keytruda for growth as exclusivity loss nears, with new combos and launches aiming to ease reliance.
Merck CEO addresses RFK Jr.'s removal of all members of CDC's vaccine advisory committee
10:49am, Tuesday, 10'th Jun 2025
CNBC's Angelica Peebles reports on news regarding vaccines.
The Highest-Quality Dividend Contenders By Quality Scores
09:00am, Tuesday, 10'th Jun 2025
The article presents the highest-quality Dividend Contenders, companies listed on U.S. exchanges with higher annual dividend payouts for 10-24 consecutive years. I use a quality scoring system with si
DARMSTADT, Germany--(BUSINESS WIRE)--Merck, a leading science and technology company, today announced that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (N
FDA approves Merck's RSV shot for infants, ramping up competition with Sanofi and AstaZeneca
03:30pm, Monday, 09'th Jun 2025
The Food and Drug Administration approved Merck's shot designed to protect infants from respiratory syncytial virus during their first season of the virus. The decision will allow the company to launc
US FDA approves Merck's RSV antibody for infants
03:16pm, Monday, 09'th Jun 2025
The U.S. Food and Drug Administration on Monday approved Merck's preventive antibody shot to protect infants up to one year of age from respiratory syncytial virus during their first RSV season, the c
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--U.S. FDA Approves Merck's ENFLONSIA for Prevention of RSV Lower Respiratory Tract Disease in Infants Born During or Entering Their First RSV Season.
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
09:19am, Monday, 09'th Jun 2025
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high
Merck's cholesterol drug meets main goal in late-stage studies
06:59am, Monday, 09'th Jun 2025
Merck said on Monday its drug met the main goal of reducing a type of cholesterol in two late-stage studies.
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck Announces Positive Topline Results from Phase 3 CORALreef Trials Evaluating Enlicitide Decanoate for the Treatment of Adults with Hyperlipidemia.
5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 10% (June 2025)
08:00am, Saturday, 07'th Jun 2025
This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering significant discounts to their historical norms. We go over our filter
